Talde invests in AJL Ophtalmic

Following the deal, AJL's founder and CEO will stay on with the business as manager and shareholder.

Talde typically invests tickets of €5-15m to acquire majority or qualified minority stakes in Spanish SMEs with enterprise values in the €15-70m range.

Talde and KCE intend to consolidate AJL's market position in the ophthalmology sector, both in Spain and internationally, as well as promote its development in complementary segments of the medical industry.

The company also plans to further invest in its R&D division, which works in partnership with universities, ophthalmologists and medical centres, with the aim of improving its technological innovation and expand its product offering.

Company
Established in 1992 and headquartered in Álava, in the Basque Country, AJL specialises in the design, manufacture and distribution of intraocular lens and implants used in ophthalmology.

The company has production facilities in Alava, Spain, and Chicago, US, and a commercial presence in more than 70 countries worldwide.

People
Talde Private Equity – José María Zalbidegoitia (chair).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• Southern Europe
• Healthcare
• Spain